Technology tested was the bipolar ionization technology used in the 7000 and BAR series. Objective was to evaluate the efficacy of the 7000 series and the Plasma BAR in reducing airborne bacteria: Escherichia coli and Staphylococcus aureus (MRSA), mold: Aspergillus niger and Cladosporium cladosporioides, and yeast Candida albicans.
An environmental chamber was set up for the testing. A nebulizer was connected to an air compressor with 1/4-inch plastic tubing and to the environmental test chamber through one of the openings.
Summary of Results
Testing showed a 99.43% reduction of Escherichia coli, an 81.67% reduction of Staphylococcus aureus, a 97.14% reduction of Aspergillus niger, a 97.69% reduction of Candida albicans and 36.27% reduction of Cladosporium cladospoioides.